Zai Lab rakes in over $100 mln Series B
China-based biopharmaceutical company Zai Lab Ltd has raised over $100 million in Series B funding. Advantech Capital led the round with participation from OrbiMed, Qiming Ventures, Sequoia Capital China and TF Capital.
11 January 2016•2 mins read
